JP2015517458A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015517458A5 JP2015517458A5 JP2015509430A JP2015509430A JP2015517458A5 JP 2015517458 A5 JP2015517458 A5 JP 2015517458A5 JP 2015509430 A JP2015509430 A JP 2015509430A JP 2015509430 A JP2015509430 A JP 2015509430A JP 2015517458 A5 JP2015517458 A5 JP 2015517458A5
- Authority
- JP
- Japan
- Prior art keywords
- insulin
- combination
- des
- human insulin
- glu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12166251.4 | 2012-05-01 | ||
| EP12166252.2 | 2012-05-01 | ||
| EP12166252 | 2012-05-01 | ||
| EP12166251 | 2012-05-01 | ||
| US201261641544P | 2012-05-02 | 2012-05-02 | |
| US201261641540P | 2012-05-02 | 2012-05-02 | |
| US61/641,540 | 2012-05-02 | ||
| US61/641,544 | 2012-05-02 | ||
| PCT/EP2013/059073 WO2013164375A1 (en) | 2012-05-01 | 2013-05-01 | Pharmaceutical composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015517458A JP2015517458A (ja) | 2015-06-22 |
| JP2015517458A5 true JP2015517458A5 (enExample) | 2016-06-16 |
| JP6262206B2 JP6262206B2 (ja) | 2018-01-17 |
Family
ID=49514218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015509430A Active JP6262206B2 (ja) | 2012-05-01 | 2013-05-01 | 医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9884094B2 (enExample) |
| EP (1) | EP2844274B1 (enExample) |
| JP (1) | JP6262206B2 (enExample) |
| AU (1) | AU2013255880B2 (enExample) |
| BR (1) | BR112014026442A8 (enExample) |
| CA (1) | CA2872083A1 (enExample) |
| MX (1) | MX363119B (enExample) |
| RU (1) | RU2670106C2 (enExample) |
| WO (1) | WO2013164375A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090074882A1 (en) | 2005-12-28 | 2009-03-19 | Novo Nordisk A/S | Insulin compositions and method of making a composition |
| BR112013010345A2 (pt) | 2010-10-27 | 2017-07-25 | Novo Nordisk As | tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção |
| US20160296602A1 (en) * | 2013-03-20 | 2016-10-13 | Novo Nordisk A/S | Dosing Regimen |
| JP2016519127A (ja) | 2013-04-30 | 2016-06-30 | ノヴォ ノルディスク アー／エス | 新規投与レジメン |
| WO2016001185A1 (en) * | 2014-07-02 | 2016-01-07 | Novo Nordisk A/S | Dosage regimen for the treatment of diabetes |
| US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
| US12343383B2 (en) | 2019-07-12 | 2025-07-01 | Novo Nordisk A/S | High concentration insulin formulation |
| WO2025104600A1 (en) * | 2023-11-15 | 2025-05-22 | Ambio, Inc. | Insulin analogs for the treatment of human metabolic disorder and disease |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| NZ222907A (en) | 1986-12-16 | 1990-08-28 | Novo Industri As | Preparation for intranasal administration containing a phospholipid absorption enhancing system |
| AU641631B2 (en) | 1988-12-23 | 1993-09-30 | Novo Nordisk A/S | Human insulin analogues |
| PT93057B (pt) | 1989-02-09 | 1995-12-29 | Lilly Co Eli | Processo para a preparacao de analogos da insulina |
| ES2136595T5 (es) | 1989-04-19 | 2004-04-01 | Enzon, Inc. | Carbonatos activos de oxidos de polialquileno para la modificacion de polipeptidos. |
| SI0792290T1 (en) | 1993-09-17 | 2001-12-31 | Novo Nordisk As | Acylated insulin |
| US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| CO4970787A1 (es) * | 1997-12-23 | 2000-11-07 | Lilly Co Eli | Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea |
| ES2472421T3 (es) | 2003-08-05 | 2014-07-01 | Novo Nordisk A/S | Nuevos derivados de insulina |
| EP2107069B1 (en) | 2003-08-05 | 2013-01-16 | Novo Nordisk A/S | Novel insulin derivatives |
| US20090074882A1 (en) | 2005-12-28 | 2009-03-19 | Novo Nordisk A/S | Insulin compositions and method of making a composition |
| BRPI0712041A2 (pt) | 2006-05-09 | 2011-12-27 | Novo Nordisk As | derivado de insulina |
| JP5552046B2 (ja) | 2007-06-13 | 2014-07-16 | ノボ・ノルデイスク・エー／エス | インスリン誘導体を含有する薬学的製剤 |
| US8802816B2 (en) * | 2008-02-19 | 2014-08-12 | Biocon Limited | Method of obtaining a purified, biologically active heterologous protein |
| KR20110085985A (ko) | 2008-10-30 | 2011-07-27 | 노보 노르디스크 에이/에스 | 하루 한번 주사 빈도보다 적은 인슐린 주사를 사용한 진성 당뇨병의 치료 |
| US20130261051A1 (en) | 2010-10-27 | 2013-10-03 | Thue Johansen | Treating Diabetes Melitus Using Insulin Injections Administered With Varying Injection Intervals |
-
2013
- 2013-05-01 EP EP13721650.3A patent/EP2844274B1/en active Active
- 2013-05-01 WO PCT/EP2013/059073 patent/WO2013164375A1/en not_active Ceased
- 2013-05-01 US US14/398,018 patent/US9884094B2/en active Active
- 2013-05-01 MX MX2014013091A patent/MX363119B/es unknown
- 2013-05-01 AU AU2013255880A patent/AU2013255880B2/en active Active
- 2013-05-01 CA CA 2872083 patent/CA2872083A1/en not_active Withdrawn
- 2013-05-01 RU RU2014147674A patent/RU2670106C2/ru active
- 2013-05-01 BR BR112014026442A patent/BR112014026442A8/pt not_active Application Discontinuation
- 2013-05-01 JP JP2015509430A patent/JP6262206B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5669395B2 (ja) | 新規化合物および摂食行動に対するその効果 | |
| RU2014147674A (ru) | Фармацевтическая композиция | |
| JP2016516076A5 (enExample) | ||
| RU2011117645A (ru) | Лечение сахарного диабета с использованием инъекций инсулина с частотой менее одного раза в день | |
| JP2009533460A (ja) | ｈＧＬＰ−１、エクセンジン−４およびその類似体の医薬組成物 | |
| JP2017537894A (ja) | Ｇｌｐ−１ｒおよびｇｌｐ−２ｒ二重アゴニスト活性を有する組成物及びペプチド | |
| RU2013133803A (ru) | Способы лечения метаболических нарушений и ожирения при помощи пептидов на основе глюкагона, активных по отношению к рецепторам гип и гпп | |
| CA2608311A1 (en) | Glp-1 pegylated compounds | |
| JP2010031018A5 (enExample) | ||
| JP2014504597A (ja) | アシル化グルカゴン類似体とインスリン類似体の組合せ物 | |
| RU2006144821A (ru) | Пролонгирующие метки полипептидов, содержащие тетразольную группировку | |
| JP2015110631A5 (enExample) | ||
| CN102711805A (zh) | 包含glp-1激动剂、胰岛素和甲硫氨酸的药物组合物 | |
| JP2011503152A5 (enExample) | ||
| US20150111820A1 (en) | Novel use of insulin derivatives | |
| EP1888103B1 (en) | Use of glp-1, exendin and agonists thereof to delay or prevent cardiac remodeling | |
| JP2024038042A (ja) | 肥満の治療および体重管理のためのｇｌｐ－１組成物 | |
| JP2014500244A5 (enExample) | ||
| Verge et al. | Impact of GLP-1 and GLP-1 receptor agonists on cardiovascular risk factors in type 2 diabetes | |
| JP2013511287A5 (enExample) | ||
| Mikhail | Is exenatide a useful addition to diabetes therapy? | |
| Skurikhin et al. | Effects of Pegylated Glucagon-Like Peptide-1 Analogue in C57Bl/6 Mice under Optimal Conditions and During Streptozotocin-Induced Diabetes | |
| Kanaujia et al. | BEYOND BORDERS: TIRZEPATIDE UNVEILED-A COMPREHENSIVE REVIEW OF DUAL TARGETING THERAPIES IN DIABETES AND OBESITY MANAGEMENT. | |
| KR20260022330A (ko) | 대사 장애의 치료에 사용하기 위한 glp-1 유사체 | |
| NZ753010A (en) | Acylated glp-1/glp-2 dual agonists |